134 related articles for article (PubMed ID: 18073348)
1. Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.
Le Toriellec E; Despouy G; Pierron G; Gaye N; Joiner M; Bellanger D; Vincent-Salomon A; Stern MH
Blood; 2008 Feb; 111(4):2321-8. PubMed ID: 18073348
[TBL] [Abstract][Full Text] [Related]
2. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
4. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
[TBL] [Abstract][Full Text] [Related]
5. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.
Feurstein S; Rücker FG; Bullinger L; Hofmann W; Manukjan G; Göhring G; Lehmann U; Heuser M; Ganser A; Döhner K; Schlegelberger B; Steinemann D
BMC Genomics; 2014 Sep; 15(1):784. PubMed ID: 25213837
[TBL] [Abstract][Full Text] [Related]
7. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
[TBL] [Abstract][Full Text] [Related]
8. T-cell prolymphocytic leukemia with der(11)t(1;11)(q21;q23) and ATM deficiency.
Yamaguchi M; Yamamoto K; Miki T; Mizutani S; Miura O
Cancer Genet Cytogenet; 2003 Oct; 146(1):22-6. PubMed ID: 14499692
[TBL] [Abstract][Full Text] [Related]
9. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
10. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
Bug S; Dürig J; Oyen F; Klein-Hitpass L; Martin-Subero JI; Harder L; Baudis M; Arnold N; Kordes U; Dührsen U; Schneppenheim R; Siebert R
Cancer Genet Cytogenet; 2009 Jul; 192(1):44-7. PubMed ID: 19480937
[TBL] [Abstract][Full Text] [Related]
11. Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia.
Hetet G; Dastot H; Baens M; Brizard A; Sigaux F; Grandchamp B; Stern MH
Hematol J; 2000; 1(1):42-7. PubMed ID: 11920168
[TBL] [Abstract][Full Text] [Related]
12. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
13. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: a novel mutation target of microsatellite instability.
Ejima Y; Yang L; Sasaki MS
Int J Cancer; 2000 Apr; 86(2):262-8. PubMed ID: 10738255
[TBL] [Abstract][Full Text] [Related]
15. Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.
Zhang P; Bhakta KS; Puri PL; Newbury RO; Feramisco JR; Wang JY
Cancer Biol Ther; 2003; 2(1):87-91. PubMed ID: 12673126
[TBL] [Abstract][Full Text] [Related]
16. Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.
Schrader A; Crispatzu G; Oberbeck S; Mayer P; Pützer S; von Jan J; Vasyutina E; Warner K; Weit N; Pflug N; Braun T; Andersson EI; Yadav B; Riabinska A; Maurer B; Ventura Ferreira MS; Beier F; Altmüller J; Lanasa M; Herling CD; Haferlach T; Stilgenbauer S; Hopfinger G; Peifer M; Brümmendorf TH; Nürnberg P; Elenitoba-Johnson KSJ; Zha S; Hallek M; Moriggl R; Reinhardt HC; Stern MH; Mustjoki S; Newrzela S; Frommolt P; Herling M
Nat Commun; 2018 Feb; 9(1):697. PubMed ID: 29449575
[TBL] [Abstract][Full Text] [Related]
17. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
18. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.
Soulier J; Pierron G; Vecchione D; Garand R; Brizard F; Sigaux F; Stern MH; Aurias A
Genes Chromosomes Cancer; 2001 Jul; 31(3):248-54. PubMed ID: 11391795
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
[TBL] [Abstract][Full Text] [Related]
20. CLL variants and T-cell-related issues.
Catovsky D
Hematol Cell Ther; 2000 Jun; 42(1):15-9. PubMed ID: 11036945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
